Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis
CRD SUMMARY: The authors concluded that neoadjuvant chemotherapy could improve tumour stage and survival rates in patients with locally advanced stomach cancer and had a good safety profile. The review findings were based on data from trials of diverse design and cointerventions, so they should be interpreted with caution.
